Invention Grant
- Patent Title: Method for diagnosing a rhinovirus infection
-
Application No.: US13504766Application Date: 2010-11-02
-
Publication No.: US09638694B2Publication Date: 2017-05-02
- Inventor: Rudolf Valenta , Katarzyna Niespodziana , Johanna Edlmayr , Dieter Blaas , Verena Niederberger-Leppin , Nikos Papadopoulos , Theresia Popow-Kraupp
- Applicant: Rudolf Valenta , Katarzyna Niespodziana , Johanna Edlmayr , Dieter Blaas , Verena Niederberger-Leppin , Nikos Papadopoulos , Theresia Popow-Kraupp
- Applicant Address: AT Vienna
- Assignee: Viravaxx GmbH
- Current Assignee: Viravaxx GmbH
- Current Assignee Address: AT Vienna
- Agency: Nevrivy Patent Law Group P.L.L.C.
- Priority: EP09174613 20091030
- International Application: PCT/AT2010/000416 WO 20101102
- International Announcement: WO2011/050384 WO 20110505
- Main IPC: C12Q1/02
- IPC: C12Q1/02 ; C12Q1/04 ; C12Q1/70 ; A61K39/12 ; G01N33/569
Abstract:
The present invention relates to a pharmaceutical composition comprising at least one peptide consisting of a minimum of 8 and a maximum of 50 amino acid residues comprising amino acid residues 1 to 8 of a rhinovirus capsid protein selected from the group consisting of VP1, VP2, VP3 and VP4.
Public/Granted literature
- US20120213820A1 Pharmaceutical composition for the treatment and prevention of a rhinovirus infection Public/Granted day:2012-08-23
Information query
